Localization of cytokines in cholesteatoma tissue.
Acquired cholesteatoma is associated with an intense inflammatory reaction with resultant tissue and bone destruction. Cytokines are molecules released by inflammatory cells at the site of infection and are potent mediators of inflammation and the immune response. Five cytokines, tumor necrosis factor-alpha, transforming growth factor-beta 1 and 2, and interleukin-1 and 6, were immunolocalized in human cholesteatoma epithelium and subepithelial stroma, with greater intensity of staining compared with noninflamed external auditory canal skin. Increased interleukin-6 activity in cholesteatoma epithelium and stroma correlated significantly with the presence of ossicular and bony erosion and granulation tissue noted intraoperatively. Transforming growth factor-beta 2 activity in cholesteatoma epithelium correlated significantly with bony erosion at surgery. Additionally, transforming growth factor-beta 1 activity in cholesteatoma epithelium correlated significantly with increased length of disease. Tumor necrosis factor-alpha, interleukin-1, and interleukin-6 appear to be involved in the inflammation and resultant remodeling associated with cholesteatoma. We hypothesized a protective function of transforming growth factor-beta 1 and 2 in the presence of cholesteatoma. The antiinflammatory and osteoclast and keratinocyte inhibitory actions of the transforming growth factor-beta s could potentially slow the proliferation and resultant tissue destructiveness associated with cholesteatoma.
Marenda
S A
SA
Department of Otolaryngology-Head and Neck Surgery, University of Texas Health Science Center.
Aufdemorte
T B
TB
D000293:Adolescent; D000328:Adult; D000368:Aged; D001862:Bone Resorption / Q000276:immunology / Q000473:pathology; D002648:Child; D018424:Cholesteatoma, Middle Ear / Q000276:immunology* / Q000473:pathology; D016207:Cytokines / Q000032:analysis*; D004424:Ear Canal / Q000276:immunology; D004429:Ear Ossicles / Q000473:pathology; D004848:Epithelium / Q000276:immunology; D005260:Female; D006097:Granulation Tissue / Q000276:immunology / Q000473:pathology; D006801:Humans; D007375:Interleukin-1 / Q000032:analysis; D015850:Interleukin-6 / Q000032:analysis; D008297:Male; D008875:Middle Aged; D012867:Skin / Q000276:immunology; D013194:Staining and Labeling; D013701:Temporal Bone / Q000276:immunology / Q000473:pathology; D016212:Transforming Growth Factor beta / Q000032:analysis; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
D016207:Cytokines; D007375:Interleukin-1; D015850:Interleukin-6; D016212:Transforming Growth Factor beta; D014409:Tumor Necrosis Factor-alpha